This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Nov 1;357(18):1841-54.

doi: 10.1056/NEJMra071371.

Leukotrienes

Marc Peters-Golden¹, William R Henderson Jr

Affiliations

Affiliation

¹ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor 48109-5642, USA. petersm@umich.edu

PMID: 17978293
DOI: 10.1056/NEJMra071371

Review

Leukotrienes

Marc Peters-Golden et al. N Engl J Med. 2007.

. 2007 Nov 1;357(18):1841-54.

doi: 10.1056/NEJMra071371.

Authors

Marc Peters-Golden¹, William R Henderson Jr

Affiliation

¹ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor 48109-5642, USA. petersm@umich.edu

PMID: 17978293
DOI: 10.1056/NEJMra071371

No abstract available

PubMed Disclaimer

Comment in

Leukotrienes.
Taccone-Gallucci M, Manca-di-Villahermosa S, Maccarrone M. Taccone-Gallucci M, et al. N Engl J Med. 2008 Feb 14;358(7):746; author reply 746. doi: 10.1056/NEJMc073333. N Engl J Med. 2008. PMID: 18272901 No abstract available.

Similar articles

Treatment of asthma with drugs modifying the leukotriene pathway.
Drazen JM, Israel E, O'Byrne PM. Drazen JM, et al. N Engl J Med. 1999 Jan 21;340(3):197-206. doi: 10.1056/NEJM199901213400306. N Engl J Med. 1999. PMID: 9895400 Review. No abstract available.
[Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M. Bäck M. Bull Acad Natl Med. 2006 Oct;190(7):1511-8; discussion 1518-21. Bull Acad Natl Med. 2006. PMID: 17450683 Review. French.
Leukotriene inhibition in small animal medicine.
Goodman L, Coles TB, Budsberg S. Goodman L, et al. J Vet Pharmacol Ther. 2008 Oct;31(5):387-98. doi: 10.1111/j.1365-2885.2008.00963.x. J Vet Pharmacol Ther. 2008. PMID: 19000257 Review.
[Trend in chemical mediator research in asthma and its application for asthma treatment].
Fukuda T. Fukuda T. Nihon Kokyuki Gakkai Zasshi. 2003 Sep;41(9):595-9. Nihon Kokyuki Gakkai Zasshi. 2003. PMID: 14531291 Review. Japanese. No abstract available.
[Are leukotriene antagonists effective in bronchial asthma?].
Costantino S. Costantino S. Clin Ter. 2002 Sep-Oct;153(5):303-4. Clin Ter. 2002. PMID: 12510412 Italian. No abstract available.

See all similar articles

Cited by

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study.
Follows RM, Snowise NG, Ho SY, Ambery CL, Smart K, McQuade BA. Follows RM, et al. Respir Res. 2013 May 17;14(1):54. doi: 10.1186/1465-9921-14-54. Respir Res. 2013. PMID: 23682661 Free PMC article. Clinical Trial.
Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19.
Zhang Q, Meng Y, Wang K, Zhang X, Chen W, Sheng J, Qiu Y, Diao H, Li L. Zhang Q, et al. Front Immunol. 2021 Feb 18;12:631226. doi: 10.3389/fimmu.2021.631226. eCollection 2021. Front Immunol. 2021. PMID: 33679778 Free PMC article. Clinical Trial.
A leukotriene C4 synthase inhibitor with the backbone of 5-(5-methylene-4-oxo-4,5-dihydrothiazol-2-ylamino) isophthalic acid.
Ago H, Okimoto N, Kanaoka Y, Morimoto G, Ukita Y, Saino H, Taiji M, Miyano M. Ago H, et al. J Biochem. 2013 May;153(5):421-9. doi: 10.1093/jb/mvt007. Epub 2013 Jan 31. J Biochem. 2013. PMID: 23378248 Free PMC article.
GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands.
Sorgi CA, Rose S, Court N, Carlos D, Paula-Silva FW, Assis PA, Frantz FG, Ryffel B, Quesniaux V, Faccioli LH. Sorgi CA, et al. PLoS One. 2012;7(7):e40523. doi: 10.1371/journal.pone.0040523. Epub 2012 Jul 13. PLoS One. 2012. PMID: 22808181 Free PMC article.
Distinct mechanisms of type 3 secretion system recognition control LTB4 synthesis in neutrophils and macrophages.
Brady A, Mora Martinez LC, Hammond B, Whitefoot-Keliin KM, Haribabu B, Uriarte SM, Lawrenz MB. Brady A, et al. PLoS Pathog. 2024 Oct 18;20(10):e1012651. doi: 10.1371/journal.ppat.1012651. eCollection 2024 Oct. PLoS Pathog. 2024. PMID: 39423229 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information